Showing results (71-80 of 165) with videos related to
Sort By:
Pageof 17
Experimental and Clinical Psychopharmacology|August 6, 2009
Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokineticsSharon L Walsh, William W Stoops, David E Moody, et al.Addiction Science & Clinical Practice|November 30, 2023
Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a "hub with many spokes" modelHannah K Knudsen, Patricia R Freeman, Douglas R Oyler, et al.Journal of Clinical Psychopharmacology|June 15, 2016
A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical TrialsAidan J Hampson, Shanna Babalonis, Michelle R Lofwall, et al.Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care|December 27, 2023
Get It in Writing: How to Make Medications for Opioid Use Disorder Available During IncarcerationMargaret McGladrey, Jordan Kelsch, Michelle R Lofwall, et al.Substance Abuse Treatment, Prevention, and Policy|August 18, 2017
A mixed methods study of HIV-related services in buprenorphine treatmentHannah K Knudsen, Jennifer Cook, Michelle R Lofwall, et al.Drug and Alcohol Dependence|November 17, 2019
Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting systemRachel Vickers-Smith, Jiangwen Sun, Richard J Charnigo, et al.Substance Abuse Treatment, Prevention, and Policy|April 2, 2025
Barriers and facilitators to scaling up medications for opioid use disorder in Kentucky: qualitative perspectives of treatment organization staffHannah K Knudsen, Shaquita Andrews-Higgins, Sandra Back-Haddix, et al.Research Square|December 23, 2024
Scaling up medications for opioid use disorder in Kentucky: Qualitative perspectives of treatment organizationsHannah K Knudsen, Shaquita Andrews-Higgins, Sandra Back-Haddix, et al.Drug and Alcohol Dependence|May 21, 2017
A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawalCharles W Gorodetzky, Sharon L Walsh, Peter R Martin, et al.Psychopharmacology|June 16, 2019
Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humansShanna Babalonis, Michelle R Lofwall, Paul A Sloan, et al.Pageof 17